Teva Pharmaceutical Industries Ltd

BNP PARIBAS FINANCIAL MARKETS TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

561,231

Value ($000)

17,516

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	17,516	0.0%	561,231	12/31/2025
2025 Q3	11/13/2025	12,635	0.0%	625,508	9/30/2025
2025 Q2	8/14/2025	15,240	0.0%	909,306	6/30/2025
2025 Q1	5/14/2025	12,529	0.0%	815,181	3/31/2025
2024 Q4	2/14/2025	29,478	0.0%	1,337,470	12/31/2024
2024 Q3	11/13/2024	21,061	0.0%	1,168,771	9/30/2024
2024 Q2	8/13/2024	27,898	0.0%	1,716,774	6/30/2024
2024 Q1	5/1/2024	29,243	0.0%	2,072,506	3/31/2024
2023 Q4	2/14/2024	14,899	0.0%	1,427,153	12/31/2023
2023 Q3	11/14/2023	11,838	0.0%	1,160,574	9/30/2023
2023 Q2	8/9/2023	10,166	0.0%	1,350,009	6/30/2023
2023 Q1	5/12/2023	11,393	0.0%	1,287,369	3/31/2023
2022 Q4	2/14/2023	11,917	0.0%	1,306,721	12/31/2022
2022 Q3	11/16/2022	10,540	0.0%	1,306,058	9/30/2022
2022 Q2	8/12/2022	8,472	0.0%	1,126,656	6/30/2022
2022 Q1	5/18/2022	8,976	0.0%	955,962	3/31/2022
2021 Q4	2/9/2022	12,828	0.0%	1,601,500	12/31/2021
2021 Q3	11/16/2021	14,590	0.0%	1,497,982	9/30/2021
2021 Q2	8/10/2021	20,612	0.0%	2,081,990	6/30/2021
2021 Q1	5/7/2021	18,531	0.0%	1,605,842	3/31/2021
2020 Q4	2/10/2021	17,620	0.1%	1,825,890	12/31/2020
2020 Q3	10/30/2020	11,994	0.0%	1,331,236	9/30/2020
2020 Q2	8/6/2020	13,824	0.0%	1,121,178	6/30/2020
2020 Q1	5/13/2020	7,928	0.0%	882,835	3/31/2020
2019 Q4	2/12/2020	10,283	0.0%	1,049,249	12/31/2019
2014 Q1	5/13/2014	7,024	0.0%	143,762	3/31/2014
2013 Q4	2/12/2014	12,496	0.0%	230,961	12/31/2013